Abstract

The peptides, histogranin and [Ser 1]histogranin, were recently shown to modulate NMDA receptor function. In the present study, the effects of intracerebroventricular (i.c.v.) administration of [Ser 1]histogranin and of the histogranin receptor antagonist, histogranin-(1–10), were examined on step-down type passive avoidance learning in mice. [Ser 1]Histogranin (30–60 nmol) impaired retention, after post-training administration, but not when it was administered just prior to the retention assay. Histogranin-(1–10) (60 nmol) facilitated learning during training, without affecting retention. Co-administration of histogranin-(1–10) with [Ser 1]histogranin (60 nmol each) led to a significant prevention of [Ser 1]histogranin-induced learning impairment. These results indicate that [Ser 1]histogranin impairs passive avoidance learning according to the pattern of NMDA receptor antagonists and involving specific histogranin sites.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.